APRI (Aprinoia Therapeutics) Earnings Power Value (EPV): $-0.62 (As of Dec23)


What is Aprinoia Therapeutics Earnings Power Value (EPV)?

Aprinoia Therapeutics APRI Earnings Power Value (EPV) is $-0.62 as of Dec23.

As of Dec23, Aprinoia Therapeutics's earnings power value is $-0.62. *

* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.

Margin of Safety is N/A.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future. Assumption: Current profitability is sustainable.

Aprinoia Therapeutics  (NAS:APRI) Earnings Power Value (EPV) Explanation

Assumption: Current profitability is sustainable.

Earnings power value (EPV) uses a very basic equation which assumes no growth, although it does rely on an assumption about the cost of capital as well as the fact that current earnings are sustainable. It also involves several adjustments to clean up the underlying Earnings figures.

Be Aware

Though using today's earnings in calculating Earnings Power Value, GuruFocus is normalizing these earnings to the business cycle. This eliminates the effects on profitability of valuing the firm at different points in the business cycle. This means that we are considering the average earnings over 5 years.

Aprinoia Therapeutics Earnings Power Value (EPV) Related Terms

Aprinoia Therapeutics Earnings Power Value (EPV) Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Earnings Power Value (EPV) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Earnings Power Value (EPV) Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Earnings Power Value (EPV)
0.00 0.00 0.00

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Earnings Power Value (EPV) 0.00 0.00 0.00 0.00 0.00

APRI vs : Earnings Power Value (EPV) Comparison

For the Biotechnology subindustry, Aprinoia Therapeutics's Earnings Power Value (EPV), along with its competitors' market caps and Earnings Power Value (EPV) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aprinoia Therapeutics Earnings Power Value (EPV) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aprinoia Therapeutics's Earnings Power Value (EPV) distribution charts can be found below:

* The bar in red indicates where Aprinoia Therapeutics's Earnings Power Value (EPV) falls into.


Aprinoia Therapeutics Earnings Power Value (EPV) Calculation

Earnings Power Value also known as just Earnings Power is a valuation technique popularised by Bruce Greenwald, an authority on value investing at Columbia University. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. This valuation tool excludes the potential growth that a company may have so that needs to be looked at separately. Since future growth is excluded from the analysis, only the maintenance capital expenditures are subtracted from after-tax EBIT (earnings before interest and taxes) and growth capex is ignored.

What does a Earnings Power Value (EPV) of $-0.62 mean?
Aprinoia Therapeutics (APRI) has a Earnings Power Value (EPV) of $-0.62 as of Dec23. Bruce Greenwald's earnings power value focuses on current earnings without factoring in future growth. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Earnings Power Value (EPV) too high?
Aprinoia Therapeutics' current Earnings Power Value (EPV) is $-0.62.
How does Aprinoia Therapeutics' Earnings Power Value (EPV) compare to ?
Aprinoia Therapeutics' Earnings Power Value (EPV) of $-0.62 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Power Value (EPV) for a Biotechnology company?
A good Earnings Power Value (EPV) depends on the Biotechnology industry context. However, Earnings Power Value (EPV) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Power Value (EPV) mean?
A high Earnings Power Value (EPV) can signal that a stock is expensive relative to its fundamentals. Bruce Greenwald's earnings power value focuses on current earnings without factoring in future growth. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Earnings Power Value (EPV) is $-0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Earnings Power Value (EPV) of $-0.62. The current Earnings Power Value (EPV) is $-0.62. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Power Value (EPV) calculated?
Earnings Power Value (EPV) is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Earnings Power Value (EPV) is $-0.62 as of Dec23. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.